Abstract:Biocompatible micromotors utilizing Chlamydomonas Reinhardtii (CHL) have been developed for improved drug delivery and diagnostic applications in potential clinical settings. These micromotors, activated by light and magnetism, feature a core‐shell microstructure (CHL@GCS/F‐UK‐MOF) created by coating them with polysaccharides (glycol chitosan and fucoidan) and ferric metal‐organic frameworks (MOFs) that incorporate thrombolytic agents. This innovative design not only enhances drug distribution but also ensures biological safety. Under light guidance, these micromotors can effectively navigate through clots, facilitating precise thrombi diagnosis and treatment. They combine magnetic hyperthermia with photosynthetic activity to clear blockages. Thrombosis presents a critical health threat globally, with high mortality and incidence rates. Clinical treatment faces challenges such as low thrombolytic agent bioavailability, thrombosis recurrence, ischemic hypoxia damage, and neural degeneration. This study developed biocompatible Chlamydomonas Reinhardtii micromotors (CHL) with photo/magnetic capabilities to address these needs. These CHL micromotors, equipped with phototaxis and photosynthesis abilities, offer promising solutions. A core aspect of this innovation involves incorporating polysaccharides (glycol chitosan (GCS) and fucoidan (F)) into ferric Metal‐organic frameworks (MOFs), loaded with urokinase (UK), and subsequently self‐assembled onto the multimodal CHL, forming a core‐shell microstructure (CHL@GCS/F‐UK‐MOF). Under light‐navigation, CHL@GCS/F‐UK‐MOF is shown to penetrate thrombi, enhancing thrombolytic biodistribution. Combining CHL@GCS/F‐UK‐MOF with the magnetic hyperthermia technique achieves stimuli‐responsive multiple‐release, accelerating thrombolysis and rapidly restoring blocked blood vessels. Moreover, this approach attenuates thrombi‐induced ischemic hypoxia disorder and tissue damage. The photosynthetic and magnetotherapeutic properties of CHL@GCS/F‐UK‐MOF, along with their protective effects, including reduced apoptosis, enhanced behavioral function, induced Heat Shock Protein (HSP), polarized M2 macrophages, and mitigated hypoxia, are confirmed through biochemical, microscopic, and behavioral assessments. This multifunctional biomimetic platform, integrating photo‐magnetic techniques, offers a comprehensive approach to cardiovascular management, advancing related technologies.

Near-Infrared Light-Driven Multifunctional Tubular Micromotors for Treatment of Atherosclerosis

Near-infrared light-driven multifunctional metal ion (Cu2+)-loaded polydopamine nanomotors for therapeutic angiogenesis in critical limb ischemia

Multi‐Pathway Microenvironment Regulation for Atherosclerosis Therapy Based on Beta‐Cyclodextrin/L‐Arginine/Au Nanomotors with Dual‐Mode Propulsion

Platelet-derived Nanomotor Coated Balloon for Atherosclerosis Combination Therapy.

Light‐Driven Biomimetic Nanomotors for Enhanced Photothermal Therapy

Lipophilic NO-Driven Nanomotors as Drug Balloon Coating for the Treatment of Atherosclerosis

NIR-propelled Janus nanomotors for active photoacoustic imaging and synergistic photothermal/chemodynamic therapy

Dual Drive Mode Polydopamine Nanomotors for Continuous Treatment of an Inferior Vena Cava Thrombus

A nanotherapy responsive to the inflammatory microenvironment for the dual-targeted treatment of atherosclerosis

Construction of dual nanomedicines for the imaging and alleviation of atherosclerosis

Atherosclerosis treatment with nanoagent: potential targets, stimulus signals and drug delivery mechanisms

Synergistic therapeutic effect of nanomotors triggered by Near-infrared light and acidic conditions of tumor

Targeted Delivery of Nanoparticles to Blood Vessels for the Treatment of Atherosclerosis

Nitric Oxide-Driven Nanomotors with Bowl-Shaped Mesoporous Silica for Targeted Thrombolysis.

Biomimetic Self-Propelled Asymmetric Nanomotors for Cascade-Targeted Treatment of Neurological Inflammation

Phototactic/Photosynthetic/Magnetic‐Powered Chlamydomonas Reinhardtii‐Metal‐Organic Frameworks Micro/Nanomotors for Intelligent Thrombolytic Management and Ischemia Alleviation

Nanomotors as Therapeutic Agents: Advancing Treatment Strategies for Inflammation‐Related Diseases

Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia

Near Infrared Light‐Activatable Platelet‐Mimicking NIR‐II NO Nano‐Prodrug for Precise Atherosclerosis Theranostics

Multimodal Imaging-Assisted Intravascular Theranostic Photoactivation on Atherosclerotic Plaque

Carrier-Free Trehalose-Based Nanomotors Targeting Macrophages in Inflammatory Plaque for Treatment of Atherosclerosis